Tirzema (Tirzepatide) 2.5/5/7.5mg/0.5mL Single-Dose Pen | Incepta Bangladesh | GLT

Generic Information: Tirzema (Tirzepatide) — Incepta Pharmaceuticals, Bangladesh

Tirzema is the tirzepatide injection of Incepta Pharmaceuticals Ltd., one of Bangladesh's largest and most export-active manufacturers. Its official range is deliberately compact: three single-dose presentations — 2.5 mg, 5 mg and 7.5 mg, each delivered in 0.5 mL — in a prefilled pen of one dose per pack. That structure mirrors the originator's single-dose pens rather than a multi-dose device, which is a useful distinction for anyone comparing it to DIL's Tixepa multi-dose pens. It is a genuine Bangladesh generic of the dual-incretin molecule, and it does not carry the 10, 12.5 or 15 mg strengths that appear in the originator's US ladder.

What Is Tirzema (Tirzepatide) Used For?

Tirzema is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, and for weight management in obesity or overweight with a weight-related comorbidity. The three available strengths cover the initiation and early-titration portion of the tirzepatide schedule — 2.5 mg for the first four weeks, then 5 mg, then 7.5 mg — which is exactly where most new patients spend their first months of therapy. As with the whole class, it is not for type 1 diabetes and is not studied in pancreatitis.

How Does Tirzema (Tirzepatide) Work?

The active ingredient activates both the GIP receptor and the GLP-1 receptor, the two incretin pathways that coordinate insulin release, glucagon suppression, gastric emptying and appetite. Because the effect on insulin is glucose-dependent, the drug lowers blood sugar mainly when it is high, which is why the risk of hypoglycemia is low when it is used alone rather than stacked on a sulfonylurea or insulin. The once-weekly schedule comes from a fatty-acid side chain that binds albumin and extends the molecule's half-life.

Indications of Tirzema (Bangladesh Label)

The label covers type 2 diabetes for glycemic control and obesity or overweight for weight management, matching the originator's dual scope. In practice Incepta positions the three-strength range for the initiation and titration phase, with prescribers stepping a patient from 2.5 to 5 to 7.5 mg across the first months before deciding on longer-term maintenance. The standard class exclusions — type 1 diabetes, personal or family history of MTC, MEN 2 — apply.

Dosage and Administration

Tirzema is injected subcutaneously once weekly, at any time of day and with or without food, in the abdomen, thigh or upper arm, rotating the site each week. Treatment begins at 2.5 mg weekly for four weeks, then rises to 5 mg weekly, then to 7.5 mg after at least another four weeks if more control is needed. Each pack is a single 0.5 mL pen used once and discarded. A missed dose is taken as soon as possible within four days; beyond that it is skipped and the next dose is taken on schedule, with at least three days between injections.

Side Effects of Tirzema

Expect the tirzepatide gastrointestinal profile — nausea, vomiting, diarrhea, decreased appetite, constipation and abdominal pain — most noticeable when the dose is being stepped up and usually easing over time. The serious cautions are the class warnings: a risk of thyroid C-cell tumors with MTC and MEN 2 contraindicated, pancreatitis, gallbladder disease, hypoglycemia when combined with insulin or a sulfonylurea, and hypersensitivity reactions. Patients with renal impairment who develop severe gastrointestinal symptoms should have kidney function monitored.

Storage Instructions

Keep unopened Tirzema pens refrigerated at 2°C to 8°C, in the original carton and protected from light, and never freeze them. Because each pack is a single dose, there is no multi-week in-use window to manage — the pen is used once and the remainder of the course comes from fresh packs. Keep the carton out of children's reach and check expiry before injecting.

Why Choose Tirzema from GLT?

Tirzema is the single-dose Bangladesh option for buyers who want one pen per week without managing a multi-dose device, at generic economics. GLT sources sealed Incepta stock with manufacturer documentation, photographs each pack before dispatch, and quotes Tirzema alongside Tixepa and the originator so the per-month cost is clear before ordering. Questions and orders flow through WhatsApp +86 15234153837 or [email protected], with a real person answering from quotation to delivery.

How to Order Tirzema (Tirzepatide)

Send the strength (2.5, 5 or 7.5 mg), the number of pens and the destination country to WhatsApp +86 15234153837 or [email protected]. GLT replies with a formal quotation, courier options and payment instructions — usually inside one working day — and ships cold-chain with export paperwork on confirmation. Recurring orders can be scheduled ahead for an uninterrupted weekly course.

FAQ

Why only three strengths? Incepta chose to market the initiation and early-titration doses — 2.5, 5 and 7.5 mg — as single-dose pens, rather than the full six-step ladder of the originator's US range.

Is Tirzema the same as Tixepa? Same molecule, different Bangladesh manufacturer and different packaging: Tirzema is Incepta's single-dose 0.5 mL pen, while Tixepa is DIL's multi-dose 2 mL pen holding four doses.

How long does one pack last? One week — each Tirzema pack is a single 0.5 mL pen for a single injection, used once and discarded.

Can I jump from 2.5 to 7.5 mg? No — titration runs through 5 mg first, with at least four weeks on each dose, as the label specifies.

Does it require a prescription? Yes — tirzepatide is prescription-only, and a clinician should confirm the indication and screen for MTC or MEN 2 before starting.